Post
Exeliom to focus on gastric cancer landscape with immune modulating drug
Paris-based Exeliom Biosciences will focus Phase III efforts of its immune modulating drug EXL01 in gastric cancer if it succeeds …
Cerevance raises $47m to fund Phase III trial for lead Parkinson’s therapy
US-based Cerevance has secured $47m in Series B-1 extension funding to finance the upcoming Phase III trial for its lead …
Hyundai Bioscience to conduct antiviral trials for Dengue in Brazil
Hyundai Bioscience has announced plans to conduct clinical trials in Brazil for its Niclosamide-based Dengue antiviral. The company’s decision comes after …
FDA approves Freedom Biosciences’s TRD treatment trial
The US Food and Drug Administration (FDA) has approved Freedom Biosciences’s investigational new drug (IND) application for FREE001, enabling the …
Caliway Biopharmaceuticals’ cellulite study meets endpoints
Taiwanese biopharmaceutical company Caliway Biopharmaceuticals has announced that a Phase II trial of its CBL-514 injection lipolysis therapy met all …
Pruvn reports results of trial of serum glutathione supplement
US-based life science research company Pruvn Research has published preliminary findings from a human clinical trial assessing the effects of …
Syphilis, the once near-eliminated STI, is resurging in the US
Syphilis, the sexually transmitted infection (STI) that was once near elimination in the US, is now increasing at an exponential …
PharmaJet’s needle-free delivery system proves effective in published study
A study, published in the Nature Journal, demonstrates that PharmaJet’s needle-free delivery system Tropis significantly boosts immune responses against the …
Podcast #1: Doing Digital Deals in Life Sciences | Corporate Culture
Welcome to the first of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them …
Alkermes begins Phase II trial of ALKS 2680 for narcolepsy type 1
Alkermes has commenced the Vibrance-1 Phase II clinical trial to evaluate ALKS 2680 in patients with narcolepsy type 1 (NT1). ALKS …
CalciMedica enrols last patient for Phase IIb acute pancreatitis trial
CalciMedica has announced the completion of patient enrollment for its Phase IIb CARPO clinical trial, which is evaluating the efficacy …
Gain touts positive Phase I results for Parkinson’s therapy
Gain Therapeutics’ GT-02287 was found to be safe and tolerable in the Phase I trial of the therapy in healthy …
EXO Biologics hopes to gain conditional marketing from Phase I/II BPD trial
EXO Biologics is hoping to receive conditional market approval from the European Medicines Agency (EMA) for its bronchopulmonary dysplasia (BPD) …
Lykos concludes European Phase II study for PTSD
Lykos Therapeutics has completed a European Phase II study (MP18) evaluating midomafetamine (MDMA) capsules for post-traumatic stress disorder (PTSD). MP18 is …
CureVac initiates H5N1 avian influenza vaccine study
CureVac has commenced the first phase of a combined Phase I/II clinical trial of a pre-pandemic vaccine candidate targeting the …